Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

A rapid preliminary prediction model for intestinal necrosis in acute mesenteric ischemia: a retrospective study

BMC Gastroenterology volume 21, Article number: 154 (2021) Cite this article

Abstract

Background

Acute mesenteric ischemia (AMI) is a life-threatening condition. However, there is no accurate method to predict intestinal necrosis in AMI patients that may facilitate early surgical intervention. This study thus aimed to explore a simple and accurate model to predict intestinal necrosis in patients with AMI.

Methods

A single-center retrospective study was performed on the data of 132 AMI patients treated between October 2011 and June 2020. The patients were divided into the intestinal necrosis and non-intestinal necrosis groups. The clinical characteristics and laboratory data were analyzed by univariate analysis, and the variables with statistical significance were further analyzed by multivariate logistic regression analysis. The independent predictors of intestinal necrosis were determined and a logistic prediction model was established. Finally, the accuracy, sensitivity, and specificity of the model in predicting intestinal necrosis were evaluated.

Results

Univariate analysis showed that white blood cell (WBC) count, blood urea nitrogen (BUN) level, neutrophil ratio, prothrombin time (PT), and LnD-dimer were associated with intestinal necrosis. According to logistic regression multivariate analysis, WBC count, BUN level and LnD-dimer were independent predictors of intestinal necrosis. These parameters were used to establish a clinical prediction model of intestinal necrosis (CPMIN) as follows: model score = 0.349 × BUN (mmol/L) + 0.109 × WBC × 109 (109/L) + 0.394 × LnD − Dimer (ug/L) − 7.883. The area under the receiver operating characteristics (ROC) curve of the model was 0.889 (95% confidence interval: 0.833–0.944). Model scores greater than − 0.1992 predicted the onset of intestinal necrosis. The accuracy, specificity, and sensitivity of the model were 82.6%, 78.2%, and 88.3%, respectively. The proportion of intestinal necrosis in the high-risk patient group (CPMIN score ≥ − 0.1992) was much greater than that in the low-risk patient group (CPMIN score < − 0.1992; 82.7% vs. 15.0%, p < 0.001).

Conclusion

The CPMIN can effectively predict intestinal necrosis and guide early surgical intervention to improve patient prognosis. Patients with AMI who are classified as high-risk should be promptly treated with surgery to avoid the potential complications caused by delayed operation. Patients classified as low-risk group can receive non-surgical treatment. This model may help to lower the morbidity and mortality from AMI. However, this model’s accuracy should be validated by larger sample size studies in the future.

Peer Review reports

Introduction

Acute mesenteric ischemia (AMI) is a very serious gastrointestinal tract disorder with high mortality that can result from mesenteric artery embolism, mesenteric artery thrombosis or mesenteric vein thrombosis [1]. An interruption of the blood supply to the mesenteric vasculature can cause necrosis of the small intestine, which can subsequently lead to serious illness and death. The short-term mortality of AMI is high, ranging from 26 to 86% [2,3,4], and early diagnosis and timely treatment essential to improve the prognosis of AMI [5].

With the continuous improvement of computed tomography (CT) technology–particularly for patients with acute abdominal conditions–AMI can now be diagnosed in the early stages of ischemia [6]. For patients with acute ischemic bowel disease, fasting, blood volume resuscitation, oral and /or intravenous antibiotics, antiplatelets, active anticoagulation therapy and interventional therapy can be initiated if intestinal necrosis has not yet developed. Thus, early intervention can save viable intestine and improve patient prognosis [7,8,9,10,11,12].

However, it is difficult to quickly and accurately determine whether intestinal necrosis has occurred using current diagnostic methods. Typically, intestinal necrosis is considered only when the patient has apparent peritoneal irritation, bloody ascites on abdominal puncture, and exhibits worsening systemic symptoms [13, 14]. The delay in diagnosing intestinal necrosis often leads to additional intestinal tissue death, which aggravates the patient’s systemic inflammatory response. Patient mortality is therefore closely related to the development of intestinal necrosis [15]. Late surgical treatment also has limitations as extensive intestinal resection leads to short bowel syndrome in surviving patients [16].

Currently, there are few studies that examine early predictors of intestinal necrosis caused by AMI, and no consensus has been reached in this regard. Therefore, to facilitate clinical decision-making for AMI patients, we investigated the clinical and laboratory factors related to small intestine necrosis in AMI patients. Furthermore, we constructed a rapid and simple predictive model to guide treatment for patients at high risk of intestinal necrosis with the goal of reducing patient mortality from this condition.

Methods

Patients

A retrospective analysis was performed on the data of AMI patients who visited the Emergency Department of the First Affiliated Hospital of Zhejiang University School of Medicine between October 2011 and June 2020. All patients with acute abdominal complaints who visited the hospital during this timeframe were evaluated. The diagnostic criteria for AMI were symptoms of acute abdominal pain and the presence of superior mesenteric artery or vein embolism confirmed by enhanced CT examination. The exclusion criteria were chronic mesenteric ischemia without acute intestinal injury, tumor-related mesenteric ischemia, acute abdominal or intestinal obstruction secondary to diseases other than AMI, presence of underlying renal function, and patient records missing essential data required for the study.

The patients were divided into the intestinal necrosis and non-intestinal necrosis groups. Intestinal necrosis was diagnosed by surgery in all patients with the disease; diagnosis was confirmed by pathological examination of the excised specimens. All specimens were pathologically examined to confirm full thickness small bowel wall necrosis.

Ethics approval for this study was obtained from the Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine. Precautions were taken to protect the privacy of the research subjects and their information. Informed consent was obtained from all patients.

Treatment

Based on the time of symptom onset, clinical symptoms, and the results of physical, laboratory, and CT examinations, patients with suspected intestinal necrosis were treated by laparotomy. The specific surgical procedure was determined according to the patient’s condition, with options including intestinal resection, arterial embolectomy, and open-close surgery. Patients without intestinal necrosis were treated medically with anticoagulation therapy, thrombolytic therapy, interventional therapy, or other strategies as appropriate. Interventional therapy includes angiography, balloon dilatation, stent implantation and intravascular thrombolysis. Their condition was closely monitored, and those with worsening conditions were treated surgically.

Data collection

The following data was collected from the study population: age, gender, cardiovascular disease status, cause(s) of AMI, treatment status, D-dimer level, complete blood count, and measures of hepatic, renal, and coagulation functions. Relevant test and examination results performed within 1 h of patient arrival at the emergency department were considered.

Statistical analysis

All analysis was performed using SPSS software version 21.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were expressed as mean ± standard deviation (SD) or range, depending on the distribution. Categorical data were expressed as values and percentage. Differences between the two groups were determined by Student’s t-test for normally distributed continuous variables. The Chi-square test or Fisher’s exact test was used in the analysis of qualitative variables. The total WBC, neutrophil, Cr, BUN, PT and lnD-dimer level were significant (p < 0.05) through univariate analysis. Those six variables were selected and entered future analysis. To identify the risk factors of intestinal necrosis, a multivariate analysis was performed using a logistic regression model with forward elimination. Results of the multivariate analysis were presented as an odds ratio (OR) (95% confidence interval). WBC count, BUN, and LnD-dimer level were finally entered the preliminary prediction model through multivariate logistic regression analysis. A receiver operating characteristic (ROC) curve was constructed to determine the optimal threshold of continuous factors in predicting recurrence. p < 0.05 was considered to be statistically significant.

Results

Overview

A total of 132 patients with AMI were included in this study. The clinical and pathologic characteristics of the patients are summarized in Table 1. Of the 132 patients with abdominal pain, 55 patients had intestinal necrosis that was confirmed by surgery and pathological examination. There were 40 female and 92 male patients with a mean age of 62 ± 16.5 (range: 23–93) years. Furthermore, 56 patients had hypertension, and 43 had atrial fibrillation. AMI was caused by arterial embolism in 81 patients and by venous embolism in 51 patients; 72 patients received surgical treatment.

Table 1 Characteristics of patients with necrosis and without necrosis
Full size table

Predictive factors of intestinal necrosis

The results of the univariate analysis of factors associated with intestinal necrosis are shown in Tables 1 and 2. The total white blood cell (WBC) count (p < 0.001), neutrophil count (p < 0.001), creatinine (p = 0.001), blood urea nitrogen (BUN) level (p < 0.001), prothrombin time (p = 0.026) and LnD-dimer level (p < 0.001) were significantly elevated in the intestinal necrosis group compared to the non-necrosis group. There were no differences between the two groups with regards to coagulation function and aspartate aminotransferase level. Multivariable analysis using binary logistic regression showed that the significant independent predictors of intestinal necrosis in patients with AMI were WBC count (OR: 1.115, 95% CI: 1.040–1.196), BUN level (OR: 1.418, 95% CI:1.183–1.699) and LnD-dimer level (OR: 1.483, 95% CI: 1.023–2.149). These results are summarized in Table 3.

Table 2 Laboratory examination in patients with acute mesenteric ischemia
Full size table
Table 3 Multivariable analysis of factors associated with necrosis
Full size table

A clinical prediction model for intestinal necrosis (CPMIN)

WBC count, BUN, and LnD-dimer level were significantly correlated with intestinal necrosis as determined by multivariate logistic regression analysis. Based on this analysis, the clinical prediction model for intestinal necrosis (CPMIN) was established as follows: model score = 0.349 × BUN (mmol/L) + 0.109 × WBC × 109 (109/L) + 0.394 × LnD − Dimer (ug/L) − 7.883. The area under the receiver operating characteristics (ROC) curve of the model was 0.889 (95% CI: 0.833–0.944); the standard error of the model was 0.029 (Fig. 1). Using the ROC curve, the threshold value of the CPMIN for predicting the onset of intestinal necrosis was − 0.1992. Based on this value, the accuracy, sensitivity and specificity of the model were 84.1%, 78.2%, and 88.3%, respectively.

Fig. 1
figure 1

AUROC of the PMIN for predicting the incidence of intestinal necrosis. The area under the curve of the model was 0.889 (95% CI 0.833–0.944), with a standard error of 0.029

Full size image

Patients were divided into two groups based on their CPMIN score: a high-risk group (CPMIN scores ≥ − 0.1992, n = 52) and low-risk group (CPMIN scores < − 0.1992, n = 80). The proportion of patients with intestinal necrosis in the high-risk group was significantly greater than that in the low-risk group (82.7% vs. 15.0%, p < 0.001) (Fig. 2). Additionally, according to the etiology of AMI and the CPMIN score, patients were subdivided into four groups: the arterial high-risk (CPMIN score ≥ − 0.1992, n = 30), arterial low-risk (CPMIN scores < − 0.1992, n = 51), venous high-risk (CPMIN scores ≥ − 0.1992, n = 22), and venous low-risk (CPMIN scores < − 0.1992, n = 29) groups. The proportion of patients with intestinal necrosis in the arterial high-risk group was significantly higher than that in the arterial low-risk group (80.0% vs. 15.7%, p < 0.001; Fig. 3); the proportion of patients with intestinal necrosis in the venous high-risk group was also significantly higher than that in the venous low-risk group (86.4% vs. 13.7%, p < 0.001; Fig. 4).

Fig. 2
figure 2

The proportion of intestinal necrosis in the different groups. The proportion of intestinal necrosis in the high-risk group was much higher than that in the low-risk group (82.7% vs.15.0%, p < 0.001)

Full size image
Fig. 3
figure 3

The proportion of intestinal necrosis in the arterial group. The proportion of the intestinal necrosis in arterial high-risk group was significantly higher than that in low-risk group (80.0% vs.15.7%, p < 0.001)

Full size image
Fig. 4
figure 4

The proportion of the intestinal necrosis in venous group. The proportion of the intestinal necrosis in venous high-risk group was significantly higher than that in low-risk group (86.4% vs.13.7%, p < 0.001)

Full size image

Discussion

Early diagnosis of AMI is very important for the prognosis of patients. Patients with suspected AMI should be examined with enhanced CT as soon as possible [17]. A management strategy including oral antibiotics in addition to early revascularization might reduce or prevent progression of AMI towards irreversible transmural intestinal necrosis (ITIN) [12]. The establishment of Intestinal Stroke Center can provide multimodal and multidisciplinary management, the modern treatment of mesenteric ischemia in Intestinal Stroke Centers has allowed rates of resection-free survival in nearly two-thirds of patients [10, 11].

Prompt and appropriate treatment is required when intestinal necrosis occurs in patients with AMI. Surgical delays often lead to death due to disease complications such as acute intestinal failure, sepsis, multiple organ failure [18,19,20], peritonitis, and short bowel syndrome in advanced or unresected intestinal necrosis [5, 21]. The extent of the small intestine resection is independently associated with initial mortality [22,23,24]. Thus, intestinal necrosis should be identified and tissue should be removed before clinical symptoms of peritonitis and organ failure appear in order to reduce morbidity and mortality and to improve intestinal function. In addition, accurate preoperative screening can avoid unnecessary laparotomy and resection in some patients with non-transmural intestinal necrosis [25, 26]. This research may help identify the criteria for emergency surgery based on clinical presentation.

We identified BUN level, LnD-dimer level and WBC count as the parameters predictive of intestinal necrosis in AMI patients. Urea nitrogen is the primary end-product of human protein metabolism and is predominantly excreted by the kidney. When the glomerular filtration rate drops below 50% of the standard value, BUN rises rapidly. Accordingly, elevated BUN is one of the leading indicators for renal function testing. After ischemic necrosis of the small intestine, intestinal cells become hypoxic. As a result, anaerobic glycolysis is enhanced and lactic acid production increases, leading to hypoxia-associated changes in renal cells that subsequently cause inflammation. As necrosis of the small intestine progresses, blood volume, cardiac output, and renal blood flow decrease leading to increased levels of renally toxic substances in the blood; in turn, this process affects renal function and leads to increased BUN levels [27]. Wei [28] et al. found that the BUN levels significantly increase when necrosis of the small intestine occurs, including in patients with AMI. However, there are currently few studies on this association; thus, further investigation of the relationship between BUN level and ischemic necrosis of the small intestine is required.

D-dimer is the end-product of fibrin degradation and is often used for diagnosis- by-exclusion of venous thrombosis [29, 30]. There are few studies on the dynamic level of D-dimer in AMI. Intestinal necrosis causes microcirculation, blood coagulation, and blood circulation disturbances in the intestine, while tissue ischemia and hypoxia can cause coagulation disorders and microthrombosis. Therefore, coagulation function markers such as D-dimer and fibrinogen can indirectly reflect the blood circulation to the diseased abdominal organs [31,32,33]. We found that the D-dimer levels were significantly different between patients in the intestinal necrosis group and the non-intestinal necrosis group. This also indicates that an increase in the level of plasma D-dimer suggests intestinal necrosis.

When a patient develops ischemic necrosis of the intestines, the permeability of the intestinal wall decreases, and bacteria in the intestine can migrate into the abdominal cavity. This causes abdominal cavity infection, leading to an increase in WBC count [34]. In the context of AMI, elevated WBC count therefore indicates that intestinal strangulation or necrosis should be considered [35, 36]. Kassahun [37] found that an increase in WBC counts can be used as an indicator of ischemic necrosis of the small intestine through analysis of clinical manifestations, laboratory examinations, and imaging of 60 cases of ischemic necrosis of the small intestine, which can support the decision to perform surgery for intestinal necrosis. Consistent with this result, we identified a statistically significant difference in WBC counts between patients in the intestinal necrosis group and the non-intestinal necrosis group.

The predictive model of intestinal necrosis based on serum BUN and plasma D-dimer levels as well as WBC counts offers a useful tool to guide clinical decision making for AMI patients. Most previous studies on this topic have focused on inflammatory or imaging indicators to predict the need for bowel resection, but biochemical indicators have rarely been included. Our model integrates inflammatory, thrombus-related, and biochemical indicators. Based on the accuracy of our model, the CPMIN can effectively predict intestinal necrosis and guide precise early intervention. Patients with high-risk AMI (CPMIN score ≥ − 0.1992) should be promptly treated with surgery to avoid the various potential complications of delayed operation, whereas Patients in the low-risk AMI group (CPMIN score < − 0.1992) can receive non-surgical treatment (Fig. 5). Thus, using the CPMIN may help to reduce the overall mortality of intestinal necrosis.

Fig. 5
figure 5

Example of management proposal using CPMIN assessment in treatment decision in acute mesenteric ischemia. The CPMIN guides clinical decision-making. If the model score ≥ − 0.1992, surgery is recommended. If the model score < − 0.1992, conservative treatment can be taken

Full size image

This study was somewhat limited by its small sample size, which may have resulted in some bias. This model’s accuracy should be validated by larger sample size studies in the future. In the subsequent research, we will expand the sample size and/or conduct a multi-center study to further validate the CPMIN. We note that numerous studies identified lactate levels as major and independent biomarker of intestinal necrosis [26, 35, 38, 39]. In this study, some of the patients were in mild condition, and the collected data were within 1 h after the patients arrived at the emergency department. Some patients did not have lactate test. Therefore, lactate was not included in this study. We will include the study of lactate in the follow-up study. Furthermore, imaging data were not included in this study, but will be examined in follow-up studies. Professional radiologists will be invited to guide data collection and analysis. Finally, it was found in this study that some patients in the low-risk AMI group still had intestinal necrosis; further research is needed to reliably identify these patients. Nonetheless, the CPMIN presented here based on BUN level, WBC count, and D-dimer level is a simple and effective predictive model of intestinal necrosis in the context of AMI.

Availability of data and materials

The datasets generated and/or analyzed in the present study are available from the corresponding author on reasonable request.

References

  1. Kärkkäinen J, et al. Acute mesenteric ischemia is a more common cause than expected of acute abdomen in the elderly. J GastrointestSurg. 2015;19(8):1407–14.

    Article  Google Scholar 

  2. Studer P et al. The value of serial serum lactate measurements in predicting the extent of ischemic bowel and outcome of patients suffering acute mesenteric ischemia. J Gastrointest Surg. 2015.

  3. Käser S, et al. Outcome after surgery for acute right-sided colonic ischemia without feasible vascular intervention: a single center experience of 58 patients over 6 years. BMC Surg. 2015;15:31.

    Article  Google Scholar 

  4. Jones J, et al. The diagnosis of acute mesenteric ischemia: a systematic review and meta-analysis. AcadEmerg Med. 2012;60(4-supp-S):S23–S23.

    Google Scholar 

  5. Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intens Care Med. 2018;41(5):1–3.

  6. Kanasaki S, et al. Acute mesenteric ischemia: multidetector CT findings and endovascular management. Radiographics. 2018;38(3):945–61.

    Article  Google Scholar 

  7. Zettervall S, et al. Trends in treatment and mortality for mesenteric ischemia in the United States from 2000 to 2012. Ann Vasc Surg. 2017;42:111–9.

    Article  Google Scholar 

  8. Matray L, Roisin S, Sabbagh C. Arterial revascularization following acute mesenteric ischemia. J Visc Surg. 2020;157(1):53–8.

    Article  CAS  Google Scholar 

  9. Kim HK. Anticoagulation and delayed bowel resection in the management of mesenteric venous thrombosis. World J Gastroenterol. 2013;19(30).

  10. Yang S, et al. Multidisciplinary stepwise management strategy for acute superior mesenteric venous thrombosis: an intestinal stroke center experience. Thromb Res. 2015;135(1):36–45.

    Article  CAS  Google Scholar 

  11. Nuzzo A, Huguet A, Corcos O. Modern treatment of mesenteric ischemia. Presse Med. 2018;47(6):519–30.

    Article  Google Scholar 

  12. Nuzzo A, et al. Oral antibiotics reduce intestinal necrosis in acute mesenteric ischemia: a prospective cohort study. Am J Gastroenterol. 2019;114(2):348–51.

    Article  Google Scholar 

  13. Corcos O, Nuzzo A. Gastro-intestinal vascular emergencies. Best Pract Res Clin Gastroenterol. 2013;27(5):709–25.

    Article  Google Scholar 

  14. Yang S, et al. Initial transcatheter thrombolysis for acute superior mesenteric venous thrombosis. World J Gastroenterol. 2014;20(18):5483–92.

    Article  Google Scholar 

  15. Schoots I, et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004;91(1):17–27.

    Article  CAS  Google Scholar 

  16. Amiot A, et al. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. ClinNutr (Edinburgh, Scotland). 2013;32(3):368–74.

    Article  Google Scholar 

  17. Nuzzo A, et al. Normal lactate and unenhanced CT-scan result in delayed diagnosis of acute mesenteric ischemia. Am J Gastroenterol. 2020;115(11):1902–5.

    Article  Google Scholar 

  18. Endean E, et al. Surgical management of thrombotic acute intestinal ischemia. Ann Surg. 2001;233(6):801–8.

    Article  CAS  Google Scholar 

  19. Macfie J, et al. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut. 1999;45(2):223–8.

    Article  CAS  Google Scholar 

  20. Arthurs ZM, et al. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg. 2011;53(3):698–705.

    Article  Google Scholar 

  21. Liu W, et al. The clinical analysis for 43 cases of acute superior mesenteric artery thrombosis confirmed by angiography and surgery. Zhonghua Nei Ke Za Zhi. 2014;53(5):375–9.

    PubMed  Google Scholar 

  22. Eslami M, et al. Mortality of acute mesenteric ischemia remains unchanged despite significant increase in utilization of endovascular techniques. Vascular. 2016;24(1):44–52.

    Article  Google Scholar 

  23. Paladino NC et al. Predictive factors of mortality in patients with acute mesenteric ischemia. A retrospective study. Ann Ital Chirurgia. 2013;84(3).

  24. Akyldz HY, et al. The length of necrosis and renal insufficiency predict the outcome of acute mesenteric ischemia. Asian J Surg. 2014;38(1):28–32.

    Article  Google Scholar 

  25. Nuzzo A, Corcos O. Reversible acute mesenteric ischemia. N Engl J Med. 2016;375(15):e31.

    Article  Google Scholar 

  26. Nuzzo A, et al. Predictive factors of intestinal necrosis in acute mesenteric ischemia: prospective study from an intestinal stroke center. Am J Gastroenterol. 2017;112(4):597.

    Article  Google Scholar 

  27. Lalisang T, et al. Clinical practice guidelines in complicated intra-abdominal infection 2018: an indonesian perspective. Surg Infect. 2019;20(1):83–90.

    Article  Google Scholar 

  28. Wei Q, et al. Prediction model based on blood urea nitrogen and the leukocyte count for intestinal necrosis in patients with portal vein system thrombosis: a retrospective study. Ann Transl Med. 2020;8(6):326.

    Article  CAS  Google Scholar 

  29. Voros J. Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med. 2013;158(2):93–100.

    Article  Google Scholar 

  30. Fernández-Ruiz I. Biomarkers: extended predictive value of d-dimer. Nat Rev Cardiol. 2018;15(4):198.

    Article  Google Scholar 

  31. Acosta S, Nilsson TK, Björck M. D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg. 2010;91(8):991–4.

    Article  Google Scholar 

  32. Yang K, et al. The combination of D-dimer and peritoneal irritation signs as a potential indicator to exclude the diagnosis of intestinal necrosis. Medicine. 2015;94(40):e1564.

    Article  Google Scholar 

  33. Martina et al. Biochemical markers of acute intestinal ischemia: possibilities and limitations. Ann Transl Med 2018.

  34. Wang X, et al. Relative factors of transmural intestinal necrosis in acute superior mesenteric vein thrombosis. Chin J Surg. 2019;57(10):44–50.

    CAS  PubMed  Google Scholar 

  35. Canfora A, et al. Predictive factors of intestinal necrosis in acute mesenteric ischemia. Open Med (Warsaw, Poland). 2019;14:883–9.

    Article  Google Scholar 

  36. Balk RA. Systemic inflammatory response syndrome (SIRS). Virulence, 2013.

  37. Kassahun W, et al. Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch Surg. 2008;393(2):163–71.

    Article  Google Scholar 

  38. Wang X, et al. Outcomes and clinical characteristics of transmural intestinal necrosis in acute mesenteric ischemia. Scand J Gastroenterol. 2019;54(8):953–9.

    Article  CAS  Google Scholar 

  39. Wang Y, et al. Predictive risk factors of intestinal necrosis in patients with mesenteric venous thrombosis: retrospective study from a single center. Can J Gastroenterol Hepatol. 2019;2019:8906803.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not Applicable.

Funding

Not Applicable.

Author information

Authors and Affiliations

  1. Emergency and Trauma Center, The International Medical Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 1367 West Wenyi Rd.Zhejiang Province, Hangzhou, 310058, China

    Xinsuo Zhuang, Fumei Chen, Qian Zhou, Yuanrun Zhu & Xiaofeng Yang

Authors
  1. Xinsuo Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fumei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qian Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuanrun Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaofeng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XFY, designed research, performed research, analyzed data. XSZ, QZ collected data, analyzed the data and drafted the manuscript. FMC,YRZ collected and analyzed the data. All authors checked and agreed on the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiaofeng Yang.

Ethics declarations

Ethics approval and consent to participate

The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study protocol and biobank were approved by the Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine, China. Informed consent was obtained from all patients.

Consent for publication

Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhuang, X., Chen, F., Zhou, Q. et al. A rapid preliminary prediction model for intestinal necrosis in acute mesenteric ischemia: a retrospective study. BMC Gastroenterol 21, 154 (2021). https://doi.org/10.1186/s12876-021-01746-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12876-021-01746-0

Keywords

BMC Gastroenterology

ISSN: 1471-230X

Contact us